Cost-effectiveness of rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation in the Japanese healthcare setting

Masatsugu Hori, Norio Tanahashi, Sayako Akiyama, Grace Kiyabu, Julie Dorey, Rei Goto

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Cost-effectiveness of rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation in the Japanese healthcare setting'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences